Suchergebnisse - "Msaouel, Pavlos"

PubPharm (8)

1

The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy : analysis of individual patient data from IMvigor210 and IMvigor211 trials

enthalten in: BJU international | 2024

von Robesti, D. | Nocera, L. | Belladelli, F. | +8

2

The Influence of Obesity on Outcomes with Immune Checkpoint Blockade : Clinical Evidence and Potential Biological Mechanisms

enthalten in: Cells | 2023

von Hahn, A. | Venkatesh, N. | Msaouel, P. | +1

3

A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma

enthalten in: Cancers | 2023

von Nze, C. | Msaouel, P. | Derbala, M. | +5

4

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

enthalten in: The oncologist | 2023

von Alhalabi, O. | Thouvenin, J. | Négrier, S. | +13

5

Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors : a pooled meta-analysis of 1735 patients

enthalten in: Frontiers in oncology | 2023

von Kovalenko, I. | Lynn Ng, W. | Geng, Y. | +6

6

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma : a comparison of outcomes

enthalten in: BJU international | 2021

von Esagian, S. | Khaki, A. | Diamantopoulos, L. | +43

7

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

enthalten in: Journal for immunotherapy of cancer | 2021

von Siddiqui, B. | Gheeya, J. | Goswamy, R. | +16

8

Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma : A retrospective analysis of safety, tolerance, and clinical outcomes

enthalten in: Cancer medicine | 2021

von Laccetti, A. | Garmezy, B. | Xiao, L. | +18

1
[1]